Type 1 diabetes is an autoimmune disease characterized by progressive loss of pancreatic beta cells. Golimumab is a human monoclonal antibody specific for tumor necrosis factor α that has already been ...
Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...
SAN FRANCISCO — After undergoing a weight-loss regimen to achieve diabetes remission, adults with type 2 diabetes who sustain weight loss can continue to experience this benefit, according to data ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A single 14-day course of the monoclonal ...
The study covered in this summary was published in Research Square as a preprint and has not yet been peer reviewed. Nearly two thirds of Brazilian study participants with childhood-onset type 1 ...
REDWOOD CITY, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback